Drug-induced adrenocortical insufficiency

DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E27.3# 1 out of 7 registries used, show all original rules.	663
4. Check minimum number of events None	663
5. Include endpoints None	663
6. Filter based on genotype QC (FinnGen only)	643

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E273
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced adrenocortical insufficiency based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2471	1595	868
Only index persons	2275	1493	782
Unadjusted period prevalence (%)
Whole population	0.04	0.05	0.02
Only index persons	0.05	0.05	0.03
Median age at first event (years)
Whole population	57.01	57.43	56.23
Only index persons	58.04	57.88	58.36

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	643	436	207
Unadjusted period prevalence (%)	0.14	0.15	0.09
Median age at first event (years)	59.37	57.30	63.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
663: Matched controls
6630

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

+∞

307.7

663

H02AB09

ATC

hydrocortisone; systemic

855.5

307.7

583

J45.9

ICD-10 Finland

Asthma, unspecified

9.2

186.4

373

815

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

8.9

180.7

366

806

R03BB04

ATC

tiotropium bromide; inhalant

10.6

175.6

242

341

J46

ICD-10 Finland

Status asthmaticus

25.7

172.5

126

R03AK08

ATC

formoterol and beclometasone; inhalant

14.8

160.0

158

137

J45.0

ICD-10 Finland

Predominantly allergic asthma

9.9

158.5

226

329

H02AB06

ATC

prednisolone; systemic

13.6

152.5

585

2352

R03DC03

ATC

montelukast; oral

7.2

138.8

307

711

J45.1

ICD-10 Finland

Nonallergic asthma

9.8

137.0

187

255

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

221.6

125.4

126

R03AK06

ATC

salmeterol and fluticasone; inhalant

6.6

118.0

259

584

L04AX01

ATC

azathioprine; systemic

12.4

117.1

126

123

J45.8

ICD-10 Finland

Mixed asthma

16.3

116.0

104

R03DA04

ATC

theophylline; systemic, rectal

11.6

110.1

124

129

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.5

104.0

421

1584

R03AC12

ATC

salmeterol; inhalant

10.8

102.9

122

136

R96

ICPC

Asthma

6.9

100.8

191

368

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

12.4

96.5

102

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

8.1

95.5

147

226

C03CA01

ATC

furosemide; systemic

5.0

91.9

325

1074

R03BA08

ATC

ciclesonide; inhalant

6.5

87.9

171

335

J45

ICD-10 Finland

Asthma

6.1

84.7

181

387

R03BA05

ATC

fluticasone; inhalant

4.9

84.2

269

811

XG474

NOMESCO Finland

Exhalation nntrogen oxide

10.9

83.9

101

R03BA01

ATC

beclometasone; inhalant

5.3

80.8

209

528

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.6

80.3

292

968

H02AB04

ATC

methylprednisolone; systemic

5.1

79.4

218

578

L04AX03

ATC

methotrexate; systemic

5.8

77.4

171

375

J01MA14

ATC

moxifloxacin; systemic

6.1

76.8

159

328

R03AC13

ATC

formoterol; inhalant

8.0

76.2

114

168

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

7.9

75.8

114

169

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.8

75.0

134

239

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

779.1

72.6

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.4

72.1

452

2174

Z01.8

ICD-10 Finland

Other specified special examinations

4.3

71.6

280

966

M05BA04

ATC

alendronic acid; oral

6.3

70.0

135

259

WZC30

NOMESCO Finland

Teaching

4.6

69.4

218

637

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.0

68.6

185

478

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.0

68.1

329

1309

R03DC01

ATC

zafirlukast; oral

14.8

66.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

7.7

65.5

100

150

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

7.8

64.5

143

R06.0

ICD-10 Finland

Dyspnoea

3.9

64.4

300

1155

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.9

64.0

170

432

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

29.8

62.6

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

20.6

62.0

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.1

59.9

148

353

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

9.7

58.9

UJF32

NOMESCO Finland

Coloscopy

3.7

57.7

285

1126

N02AA05

ATC

oxycodone; systemic

4.1

56.4

205

656

R03AC02

ATC

salbutamol; inhalant

4.1

55.3

510

2967

R03BA02

ATC

budesonide; inhalant

3.9

54.7

223

771

105

Kela drug reimbursment

Adrenal cortical hypofunction

199.5

53.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.8

53.7

227

803

H02AB07

ATC

prednisone; oral

4.2

53.6

177

527

J01MA12

ATC

levofloxacin; systemic

3.9

52.7

207

696

N06AX21

ATC

duloxetine; oral

4.3

52.7

170

497

R50.9

ICD-10 Finland

Fever, unspecified

4.0

52.6

191

608

SPAT1148

SPAT

Treatment of chronic ulcer or burn

4.2

51.5

166

484

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

5.0

50.9

124

290

N03AX12

ATC

[U] gabapentin; oral

3.7

50.6

211

736

R03AK07

ATC

formoterol and budesonide; inhalant

3.6

50.6

237

892

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

9.8

50.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.7

50.4

212

744

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

17.4

49.1

E23.03

ICD-10 Finland

Lack of ACTH

137.9

48.5

L01BA01

ATC

methotrexate; systemic

8.1

48.4

A01AB09

ATC

miconazole; local oral

4.8

48.3

124

302

TPH04

NOMESCO Finland

Cathetrisation of vein

3.5

48.3

239

928

A07AA02

ATC

nystatin; oral

5.6

47.9

200

R53

ICD-10 Finland

Malaise and fatigue

3.4

47.3

254

1035

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

8.3

46.6

N02AX02

ATC

tramadol; systemic, rectal

3.1

45.4

393

2098

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.7

45.1

176

583

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.4

44.7

132

358

R06AE07

ATC

cetirizine; oral

3.1

44.7

403

2195

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.4

44.5

101

N03AX16

ATC

[U] pregabalin

3.2

44.4

252

1055

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

5.2

44.1

100

219

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

5.0

44.1

106

244

R02

ICPC

Shortness of breath/dyspnoea

3.9

43.8

154

474

R11

ICD-10 Finland

Nausea and vomiting

4.5

43.7

121

312

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.2

43.7

246

1023

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

15.3

43.7

L04AA06

ATC

mycophenolic acid; systemic

12.0

43.5

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.7

43.5

120

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.9

43.0

107

253

J47

ICD-10 Finland

Bronchiectasis

10.9

42.7

JN3AD

NOMESCO Finland

Abdominal CT examination

4.0

42.5

141

416

R03AK11

ATC

formoterol and fluticasone; inhalant

8.6

42.4

J01MA02

ATC

ciprofloxacin; systemic

3.0

42.2

340

1724

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

9.0

42.1

R03BB01

ATC

ipratropium bromide; inhalant

6.9

41.8

108

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

8.2

41.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

3.0

41.6

285

1319

R01AD01

ATC

beclometasone; nasal

3.5

41.5

186

671

E0000UV, ,

ATC

3.0

41.4

380

2061

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.3

41.3

123

335

C01CA24

ATC

epinephrine; parenteral

4.7

41.2

105

253

ZX120

NOMESCO Finland

Intravenous

4.2

41.1

128

360

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.7

40.9

157

511

M05BX04

ATC

denosumab; parenteral

5.6

40.7

165

SPAT1260

SPAT

Consultation of another employee

3.4

39.5

185

683

TQW80

NOMESCO Finland

Local dermatologic skincare

8.6

39.3

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

5.6

38.9

156

A02BC01

ATC

omeprazole; systemic

3.0

38.5

262

1199

SPAT1262

SPAT

Handing over of treatment supplies

3.3

37.9

179

663

SPAT1254

SPAT

Administration of medicine

3.6

37.8

153

514

L04AA13

ATC

[U] leflunomide

8.7

37.7

S18

ICPC

Laceration/cut

2.8

37.0

392

2248

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

7.8

37.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.4

37.0

167

601

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.2

36.9

111

303

SPAT1255

SPAT

Intravenous administration of medicine

5.1

36.8

184

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

5.1

36.8

180

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.5

36.7

149

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.0

36.6

117

334

A02BC05

ATC

esomeprazole; systemic

2.8

36.5

363

2011

SPAT1263

SPAT

Sampling

2.8

36.4

357

1964

SPAT1153

SPAT

Removal of sutures

2.8

36.4

289

1427

R03AC03

ATC

terbutaline; inhalant

3.4

36.2

155

539

49300

ICD-8 Finland

Asthma, bronchiale

8.9

36.0

J01FF01

ATC

clindamycin; systemic

2.9

35.8

257

1201

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.4

35.8

249

N02BF01

ATC

gabapentin; oral

4.1

35.7

112

315

TDM10

NOMESCO Finland

Puncture of maxillary antrum

5.9

35.6

123

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

7.3

34.8

H02AA02

ATC

fludrocortisone; oral

41.7

34.8

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.3

34.7

255

UDH02

NOMESCO Finland

Rhinopharyngoscopy

4.4

34.6

251

A02BC02

ATC

pantoprazole; systemic

3.3

34.1

531

3662

L04AB01

ATC

etanercept; parenteral

11.5

34.0

R06AE09

ATC

levocetirizine; oral

3.3

33.9

158

577

WZC00

NOMESCO Finland

Treatment plan or consultation

2.7

33.8

321

1719

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

9.4

33.7

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

5.9

33.6

115

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.7

33.6

120

369

R01AD08

ATC

fluticasone; nasal

2.7

33.6

271

1337

S97

ICPC

Chronic ulcer skin

4.7

33.6

194

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

6.5

33.3

A07EC01

ATC

sulfasalazine; oral, rectal

4.1

33.1

101

278

C07AB07

ATC

bisoprolol; oral

2.6

32.8

383

2258

SPAT1149

SPAT

Suture or treatment of traumatic wound

3.5

32.6

130

430

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

32.5

322

1751

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

9.6

32.4

R60.0

ICD-10 Finland

Localized oedema

3.5

32.3

130

432

NH3EA

NOMESCO Finland

Feet X-ray examination with load

8.2

32.2

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.6

32.2

362

2090

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.9

31.7

106

311

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

6.4

31.6

N06AA09

ATC

amitriptyline; systemic

3.6

31.5

119

379

L04AB04

ATC

adalimumab; parenteral

7.4

31.3

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.5

31.2

125

414

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.6

31.1

340

1928

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.9

30.8

184

771

J01FA06

ATC

roxithromycin; oral

2.5

30.6

342

1955

L04AD01

ATC

ciclosporin; systemic

9.1

30.4

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.3

30.3

135

477

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.5

30.1

372

2221

SPAT1310

SPAT

Counselling related to known health issue

2.6

30.1

279

1456

AA1AD

NOMESCO Finland

CT of head and brain

2.7

30.1

231

1100

A07EA06

ATC

budesonide; oral, local oral

5.6

30.1

116

H03AA01

ATC

levothyroxine sodium; systemic

2.7

30.0

227

1073

318

Kela drug reimbursment

Teriparatide

47.4

29.9

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.9

29.7

J32.4

ICD-10 Finland

Chronic pansinusitis

10.2

29.7

SPAT1325

SPAT

Vaccination

2.6

29.5

282

1491

R06AX26

ATC

fexofenadine; oral

3.9

29.5

271

ZYC01

NOMESCO Finland

Remote contact by phone

4.2

29.5

219

SPAT1301

SPAT

No procedures

2.6

29.5

268

1384

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.6

29.5

109

342

XQ800

NOMESCO Finland

Prick test

3.9

29.3

277

A02BA02

ATC

ranitidine; systemic

2.8

29.2

189

824

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.8

29.0

100

299

R5140

NOMESCO Finland

Monitoring the use of the aid

3.4

28.9

122

416

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

27.5

28.7

R52.2

ICD-10 Finland

Other chronic pain

5.2

28.7

129

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.0

28.7

155

612

M81.4

ICD-10 Finland

Drug-induced osteoporosis

51.0

28.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.5

28.6

427

2758

P01BA02

ATC

hydroxychloroquine; oral

3.7

28.5

103

318

L28

ICPC

Limited function/disability (L)

2.9

28.5

163

664

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.9

28.4

146

A06AD11

ATC

lactulose; oral

3.2

28.4

135

495

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

6.2

28.3

A41.9

ICD-10 Finland

Sepsis, unspecified

6.1

28.1

H05AA02

ATC

teriparatide; parenteral

44.6

28.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.2

28.0

126

447

A46

ICD-10 Finland

Erysipelas

3.1

27.9

135

500

XG410

NOMESCO Finland

Flow-volume spirometry

5.4

27.8

113

N06AX16

ATC

venlafaxine; oral

2.9

27.6

157

636

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.9

27.5

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.1

27.4

130

A02BC03

ATC

lansoprazole; oral

2.5

27.3

256

1331

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

6.6

27.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.6

27.2

102

322

G47.3

ICD-10 Finland

Sleep apnoea

2.6

27.0

207

977

M13.9

ICD-10 Finland

Arthritis, unspecified

3.9

27.0

248

A06AC01

ATC

ispaghula (psylla seeds); oral

2.5

26.9

237

1195

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.4

26.8

109

E000001, ,

ATC

2.7

26.7

184

823

SPAT1229

SPAT

Assessment of need for aid

3.9

26.7

235

M81.9

ICD-10 Finland

Osteoporosis, unspecified

5.0

26.7

129

J02AC01

ATC

fluconazole; systemic

2.4

26.4

343

2056

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.5

26.3

228

1139

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.7

26.3

147

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.6

26.1

152

ZX112

NOMESCO Finland

Subcutaneous

6.6

26.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.4

26.0

170

A07EC02

ATC

mesalazine; oral, rectal

4.3

26.0

179

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.4

26.0

103

337

C03DA01

ATC

spironolactone; oral

3.3

25.9

113

392

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

3.0

25.8

138

539

R07.4

ICD-10 Finland

Chest pain, unspecified

2.5

25.8

243

1260

J01FA09

ATC

clarithromycin; systemic

2.4

25.7

277

1526

L95

ICPC

Osteoporosis

5.4

25.6

102

R51.80

ICD-10 Finland

Headache

2.8

25.5

161

687

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.4

25.5

273

1498

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.2

25.0

108

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.7

25.0

256

L04AA01

ATC

[U] ciclosporin

10.4

24.9

E000002, ,

ATC

3.2

24.8

112

396

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.0

24.8

117

R4180

NOMESCO Finland

Podiatric therapy

9.7

24.6

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

8.2

24.5

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.5

24.3

214

1071

A03FA01

ATC

metoclopramide; systemic, rectal

2.5

24.3

206

1014

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.6

24.2

183

852

N05BA04

ATC

oxazepam; oral

2.4

24.2

228

1176

N02AJ06

ATC

codeine and paracetamol; systemic

2.3

24.2

345

2126

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

23.9

332

2021

TGC00

NOMESCO Finland

Bronchial lavation

6.2

23.8

N03AE01

ATC

clonazepam; systemic

4.1

23.7

182

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.8

23.7

Z71.8

ICD-10 Finland

Other specified counselling

2.3

23.7

262

1448

SPAT1249

SPAT

Treatment-related counselling outside office

2.3

23.4

310

1847

R03AK03

ATC

[U] fenoterol and ipratropium bromide

4.5

23.3

140

M48.0

ICD-10 Finland

Spinal stenosis

3.0

23.2

118

447

ZX114

NOMESCO Finland

Intramuscular

7.7

23.1

N03AX09

ATC

lamotrigine; oral

4.2

22.9

164

M79.7

ICD-10 Finland

Fibromyalgia

4.5

22.8

138

XX3DW

NOMESCO Finland

Time consuming IT work

3.0

22.8

116

439

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.7

22.8

236

N06AX11

ATC

mirtazapine; oral

2.3

22.7

283

1638

M54.4

ICD-10 Finland

Lumbago with sciatica

2.6

22.7

172

800

R01AD12

ATC

fluticasone furoate; nasal

2.3

22.6

268

1519

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.0

22.4

115

437

A07EA02

ATC

hydrocortisone; rectal

6.7

22.4

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.6

22.2

250

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

6.0

22.2

J01FA15

ATC

telithromycin; oral

3.1

22.1

106

387

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

5.2

22.1

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.3

22.1

309

M05BA07

ATC

risedronic acid; oral

5.8

22.1

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

22.0

238

1294

M54.5

ICD-10 Finland

Low back pain

2.2

22.0

291

1720

E27.2

ICD-10 Finland

Addisonian crisis

+∞

22.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.1

22.0

169

L88

ICPC

Rheumatoid/seropositive arthritis

4.7

21.9

121

SPAT1312

SPAT

General health counselling

2.3

21.9

256

1438

N05AH04

ATC

quetiapine; oral

2.6

21.8

161

738

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.9

21.7

121

481

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

21.7

165

767

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

5.5

21.5

N02AC04

ATC

dextropropoxyphene; oral

5.1

21.4

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.4

21.3

R03BC03

ATC

nedocromil; inhalant

3.5

21.3

257

WW200

NOMESCO Finland

Immunization

6.0

21.2

R01AD05

ATC

budesonide; nasal

3.3

21.2

279

N30.0

ICD-10 Finland

Acute cystitis

2.6

21.1

144

634

D07AC01

ATC

betamethasone; topical

2.2

21.0

284

1685

B01AB05

ATC

enoxaparin; parenteral

2.2

20.8

254

1446

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

4.2

20.8

148

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.4

20.8

J01DB01

ATC

cefalexin; oral

3.2

20.7

590

4758

E000003, ,

ATC

4.2

20.7

144

ZXA10

NOMESCO Finland

Bilateral

2.5

20.6

162

762

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

4.9

20.6

102

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

20.6

278

J30.3

ICD-10 Finland

Other allergic rhinitis

4.4

20.6

127

ZXD05

NOMESCO Finland

Urgent procedure

2.2

20.5

244

1373

K51.8

ICD-10 Finland

Other ulcerative colitis

7.7

20.5

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.2

20.4

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

20.3

379

2540

J01AA02

ATC

doxycycline; systemic

2.7

20.3

557

4377

R01AD09

ATC

mometasone; nasal

2.1

20.3

364

2403

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

7.0

20.1

S01GX01

ATC

cromoglicic acid; ophthalmic

2.4

20.1

184

926

N02BF02

ATC

pregabalin; oral

3.6

19.9

211

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

6.1

19.8

WX892

NOMESCO Finland

Monitored bed care

3.4

19.8

253

SPAT1211

SPAT

Application of soft bandage

3.2

19.7

297

E27.9

ICD-10 Finland

Disorder of adrenal gland, unspecified

205.9

19.7

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

41.5

19.6

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.2

19.6

287

J31.0

ICD-10 Finland

Chronic rhinitis

3.1

19.5

332

R52.9

ICD-10 Finland

Pain, unspecified

2.9

19.5

373

UJF92

NOMESCO Finland

Capsular endoscopy

6.5

19.4

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.2

19.4

294

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.6

19.3

130

567

J01FA10

ATC

azithromycin; systemic

2.2

19.3

441

3168

R60.9

ICD-10 Finland

Oedema, unspecified

3.8

19.2

176

R01BA52

ATC

pseudoephedrine, combinations; oral

2.2

19.1

255

1493

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

19.1

232

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.7

19.0

101

TAB00

NOMESCO Finland

Lumbar puncture

3.8

18.9

168

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.4

18.9

228

K50.8

ICD-10 Finland

Other Crohn disease

7.3

18.8

K50.9

ICD-10 Finland

Crohn disease, unspecified

7.6

18.8

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

18.7

199

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.3

18.5

120

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.2

18.5

216

1197

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.2

18.5

218

1214

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

18.4

114

476

JN4AD

NOMESCO Finland

Body CT examination

3.0

18.4

337

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

18.4

241

1397

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

18.4

227

1286

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.0

18.4

320

N05BA01

ATC

diazepam; systemic, rectal

2.6

18.3

122

528

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.3

18.3

238

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.7

18.3

177

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

18.3

177

A10AB05

ATC

insulin aspart; parenteral

3.3

18.2

250

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

15.9

18.1

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

5.2

18.0

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.8

18.0

M79.6

ICD-10 Finland

Pain in limb

2.0

17.7

323

2108

RD211, ,

NOMESCO Finland

4.0

17.7

138

D07AB08

ATC

desonide; topical

2.7

17.7

104

423

P01AB01

ATC

metronidazole; oral, rectal

2.0

17.6

316

2051

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

3.6

17.5

187

K51.5

ICD-10 Finland

Left sided colitis

5.0

17.5

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.3

17.5

172

887

Z00.0

ICD-10 Finland

General medical examination

2.3

17.4

160

802

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

17.3

100

402

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.9

17.3

331

A07AA09

ATC

vancomycin; oral

13.0

17.3

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

7.1

17.1

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

18.0

17.0

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.2

17.0

119

R01AD58

ATC

fluticasone, combinations; nasal

2.2

17.0

201

1114

C07AB02

ATC

metoprolol; systemic

2.3

17.0

150

738

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.1

16.9

266

G43.9

ICD-10 Finland

Migraine, unspecified

3.4

16.9

207

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

16.9

389

R06AX13

ATC

loratadine; oral

2.4

16.9

137

649

WX723

NOMESCO Finland

CPAP therapy

4.0

16.8

129

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.3

16.8

213

TQW11

NOMESCO Finland

Vacuum treatment of wound

6.0

16.8

EBA10

NOMESCO Finland

Operative extraction of tooth

2.6

16.7

104

435

M25.5

ICD-10 Finland

Pain in joint

2.0

16.6

265

1640

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.9

16.6

135

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.9

16.6

135

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.8

16.5

345

I50.9

ICD-10 Finland

Heart failure, unspecified

2.7

16.5

394

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.5

16.4

185

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

6.5

16.4

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

6.5

16.4

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

5.1

16.3

D07AA02

ATC

hydrocortisone; topical

2.4

16.3

128

597

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.4

16.2

L17

ICPC

Foot/toe symptom/complaint

2.1

16.2

228

1347

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.2

16.2

229

D07AD01

ATC

clobetasol; topical

2.3

16.1

145

717

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.5

16.0

112

495

WZA10

NOMESCO Finland

Extensive medical or dental certificate

6.6

15.9

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

15.9

316

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.2

15.9

N05CF01

ATC

zopiclone; oral

2.0

15.9

245

1493

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.7

15.8

377

B01AA03

ATC

warfarin; systemic

2.4

15.8

125

584

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.2

15.8

161

839

R01AD11

ATC

triamcinolone; nasal

2.7

15.7

354

ZXE20

NOMESCO Finland

More than three and less than five hours

2.4

15.6

118

540

A01

ICPC

Pain general/multiple sites

2.7

15.6

355

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.7

15.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.4

15.6

3028

Kela drug reimbursment

Mepolizumab

163.7

15.5

OAB50, ,

SPAT

3.5

15.5

166

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

15.5

124

582

A04AA01

ATC

ondansetron; systemic, rectal

2.9

15.5

303

M35.7

ICD-10 Finland

Hypermobility syndrome

6.6

15.5

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

5.4

15.5

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

15.4

130

625

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

6.9

15.4

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

15.4

152

781

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.9

15.4

281

127

Kela drug reimbursment

Transplant complication

7.2

15.3

A03FA02

ATC

cisapride; oral, rectal

3.0

15.2

248

-44

ICPC

Preventive immunization/medic

3.0

15.2

265

E66.8

ICD-10 Finland

Other obesity

3.3

15.2

189

SPAT1252

SPAT

Overall medication plan or its review

3.2

15.2

205

UDC00

NOMESCO Finland

Ear microscopy

3.0

15.1

266

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

15.1

204

1181

E87.6

ICD-10 Finland

Hypokalaemia

4.1

15.1

107

R06AX27

ATC

desloratadine; oral

2.0

15.0

228

1376

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.2

15.0

201

R81

ICPC

Pneumonia

4.4

15.0

R06AX22

ATC

ebastine; oral

2.2

15.0

148

760

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

14.9

114

524

R4190

NOMESCO Finland

Nutritional therapy

3.7

14.9

136

N03AX14

ATC

levetiracetam; systemic

4.9

14.9

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.8

14.8

132

WX725

NOMESCO Finland

Noninvasive ventilation

3.3

14.7

182

J01EA01

ATC

trimethoprim; systemic

2.0

14.7

202

1174

E66.01

ICD-10 Finland

Obesity due to excess calories

2.7

14.7

347

A01AB04

ATC

amphotericin B; local oral

3.6

14.7

152

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

5.1

14.7

SAA04

NOMESCO Finland

Special examination of mouth

3.3

14.7

188

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.6

14.6

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.4

14.6

111

508

R1250

NOMESCO Finland

Evaluation of functional capability

4.8

14.6

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

6.0

14.6

297, ,

Kela drug reimbursment

153.2

14.5

R03DX09

ATC

mepolizumab; parenteral

153.2

14.5

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

36.9

14.5

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.8

14.5

129

K29.7

ICD-10 Finland

Gastritis, unspecified

4.1

14.4

106

UDM02

NOMESCO Finland

Sinoscopy

4.9

14.4

A07DA03

ATC

loperamide; oral

4.3

14.4

SPAT1216

SPAT

Assessment of functional ability

2.3

14.3

119

567

N02BE01

ATC

paracetamol; systemic, rectal

3.0

14.3

609

5243

J01CA04

ATC

amoxicillin; systemic

2.4

14.2

566

4714

L86

ICPC

Back syndrome with radiating pain

3.1

14.2

208

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.6

14.2

360

B01AF02

ATC

apixaban; oral

2.6

14.2

385

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

43.5

14.2

K07.60

ICD-10 Finland

Snapping jaw

3.2

14.2

192

ZY010

NOMESCO Finland

Hospital outpatient

3.2

14.2

192

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.1

14.1

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

14.0

223

1363

T78.4

ICD-10 Finland

Allergy, unspecified

3.6

14.0

137

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

30.8

13.9

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

30.8

13.9

PAW37

NOMESCO Finland

Biopsy of temporal artery

30.8

13.9

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.6

13.9

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.0

13.9

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

18.0

13.9

Z3231

NOMESCO Finland

Registered nurse

2.0

13.8

209

1253

D02AE01

ATC

carbamide; topical

3.1

13.8

211

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

3.8

13.8

119

B01AB10

ATC

tinzaparin; parenteral

2.6

13.8

384

C08DA01

ATC

verapamil; systemic

3.7

13.7

124

C10AC01

ATC

colestyramine; oral

4.5

13.7

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.1

13.7

196

M01AH01

ATC

celecoxib; oral

2.2

13.7

141

734

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.1

13.6

213

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.7

13.6

306

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

6.2

13.5

WX213

NOMESCO Finland

Lower leg blockade

18.7

13.4

H04.10

ICD-10 Finland

Dry eye syndrome

2.4

13.4

103

473

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.0

13.4

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.9

13.4

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.8

13.4

112

A28

ICPC

Limited function/disability NOS

2.3

13.4

118

576

M05BB03

ATC

alendronic acid and colecalciferol; oral

5.5

13.3

SPAT1097

SPAT

Recording of ECG

2.3

13.1

115

559

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.8

13.1

269

B03BA03

ATC

hydroxocobalamin; parenteral

3.4

13.1

153

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.4

13.1

102

471

R01AC01

ATC

cromoglicic acid; nasal

3.6

13.1

128

WZC00, ,

SPAT

2.6

13.1

355

L29

ICPC

Musculoskeletal sympt/complt other

2.7

13.0

300

ZXE00

NOMESCO Finland

One hour or less

1.8

13.0

286

1929

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.0

13.0

224

RS221, ,

NOMESCO Finland

5.8

13.0

XQ802

NOMESCO Finland

Epicutan test

3.5

13.0

134

R49.08

ICD-10 Finland

Other specified dysphonia

4.6

13.0

D72.1

ICD-10 Finland

Eosinophilia

23.1

12.9

L03

ICPC

Low back symptom/complaint

1.9

12.8

208

1272

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.0

12.8

170

971

B80

ICPC

Iron deficiency anaemia

5.1

12.7

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.8

12.7

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

12.6

12.7

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

12.7

138

732

K50.0

ICD-10 Finland

Crohn disease of small intestine

5.6

12.7

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.6

12.7

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4.3

12.6

WX402

NOMESCO Finland

General anaesthesia

2.0

12.6

166

944

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.1

12.6

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

5.4

12.6

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

6.3

12.5

L29.9

ICD-10 Finland

Pruritus, unspecified

4.5

12.5

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

24.9

12.5

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

12.5

168

963

UKC02

NOMESCO Finland

Cystoscopy

2.3

12.5

111

543

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

12.4

389

C09CA06

ATC

candesartan; oral

2.0

12.4

176

1026

J96.1

ICD-10 Finland

Chronic respiratory failure

5.5

12.4

A04

ICPC

Weakness/tiredness general

2.2

12.4

111

545

K50.1

ICD-10 Finland

Crohn disease of large intestine

9.2

12.3

J33.0

ICD-10 Finland

Polyp of nasal cavity

4.5

12.3

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

12.3

249

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.2

12.2

N06AX26

ATC

vortioxetine; oral

2.8

12.2

244

101

Kela drug reimbursment

Anterior pituitary hypofunction

12.7

12.2

SCA02

NOMESCO Finland

Preventive oral health care

2.4

12.2

406

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.3

12.1

145

B35.3

ICD-10 Finland

Tinea pedis

3.5

12.1

125

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

12.1

119

606

NG1DA

NOMESCO Finland

X-ray of knees

5.4

12.1

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

12.0

246

X58

ICD-10 Finland

Exposure to other specified factors

2.2

12.0

114

573

XQ848

NOMESCO Finland

Dermatological photography

4.1

11.9

M01CB01

ATC

sodium aurothiomalate; parenteral

9.2

11.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

11.8

119

612

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

4.7

11.7

H26.3

ICD-10 Finland

Drug-induced cataract

12.8

11.7

120

Kela drug reimbursment

Hypogammaglobulinaemia

30.6

11.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

11.7

489

3959

A10BJ06

ATC

semaglutide; parenteral

3.1

11.7

170

A02BA04

ATC

nizatidine; systemic

2.8

11.7

232

R03DX10

ATC

benralizumab; systemic

66.1

11.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

11.6

114

579

N04BC05

ATC

pramipexole; oral

2.7

11.6

268

XQ820

NOMESCO Finland

Exposure to medicinal substance

19.3

11.6

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.4

11.6

401

M35.3

ICD-10 Finland

Polymyalgia rheumatica

3.5

11.5

124

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

5.8

11.5

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

13.9

11.5

M05BA06

ATC

ibandronic acid; systemic

4.8

11.5

XF600

NOMESCO Finland

Bloodpressure measurement

2.8

11.4

223

R60.1

ICD-10 Finland

Generalized oedema

12.1

11.4

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.3

11.4

438

F43.29

ICD-10 Finland

Adaptation disorder UNS

4.3

11.4

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.9

11.3

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.6

11.3

106

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.0

11.3

179

T90

ICPC

Diabetes non-insulin dependent

1.9

11.3

163

954

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.9

11.3

L20

ICPC

Joint symptom/complaint NOS

3.5

11.3

116

SPAT1131

SPAT

Colonoscopy

3.8

11.3

D02AX

ATC

Other emollients and protectives

3.8

11.3

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

17.4

11.2

N05BA06

ATC

lorazepam; systemic, sublingual

3.0

11.2

180

J01

ICD-10 Finland

Acute sinusitis

2.9

11.1

197

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

11.1

197

N06AB04

ATC

citalopram; systemic

1.9

11.1

158

918

S01

ICPC

Pain/tenderness of skin

3.3

11.1

132

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.6

11.1

107

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

4.1

11.1

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.4

11.1

S92.3

ICD-10 Finland

Fracture of metatarsal bone

3.5

11.1

112

A10AC01

ATC

insulin (human); parenteral

2.7

11.1

256

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

11.1

176

1061

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

11.1

386

2935

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

11.1

209

B03XA02

ATC

darbepoetin alfa; parenteral

5.1

11.1

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.3

11.0

133

R06.2

ICD-10 Finland

Wheezing

3.3

10.9

129

R05

ICPC

Cough

1.9

10.8

185

1141

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

10.8

380

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.8

10.8

206

N03AG01

ATC

valproic acid; systemic, rectal

2.8

10.8

206

D07AC13

ATC

mometasone; topical

1.8

10.8

208

1331

R03BC01

ATC

cromoglicic acid; inhalant

5.0

10.8

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.8

10.8

212

L99

ICPC

Musculoskeletal disease other

4.7

10.8

C01DA14

ATC

isosorbide mononitrate; oral

2.3

10.8

448

XKD00

NOMESCO Finland

Uroflowmetry

2.2

10.8

455

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

18.2

10.8

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.0

10.8

149

858

JN4BD

NOMESCO Finland

Extensive body CT

2.4

10.7

355

WX002

NOMESCO Finland

Sedation and analgesia

2.0

10.7

145

828

E23.00

ICD-10 Finland

Panhypopituitarism

21.9

10.7

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

13.2

10.7

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.7

10.7

231

SPAT1104

SPAT

Monitoring of emergency patient

2.9

10.7

196

M10.9

ICD-10 Finland

Gout, unspecified

3.0

10.7

168

3027

Kela drug reimbursment

Benralizumab

61.0

10.7

RS222, ,

NOMESCO Finland

8.7

10.6

C08CA01

ATC

amlodipine; oral

1.8

10.6

245

1654

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

10.5

294

ZZA00

NOMESCO Finland

Split skin graft

4.2

10.5

S29

ICPC

Skin symptom/complaint other

2.0

10.5

139

788

M54.6

ICD-10 Finland

Pain in thoracic spine

2.5

10.5

276

L04AC07

ATC

tocilizumab; parenteral

111.7

10.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

10.4

255

1747

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

10.4

193

R33

ICD-10 Finland

Retention of urine

2.8

10.4

193

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.0

10.3

160

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.0

10.3

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

5.0

10.3

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.8

10.3

AN1

Coronary angiography

2.4

10.3

323

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

10.2

134

756

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

8.1

10.2

L60.0

ICD-10 Finland

Ingrowing nail

3.0

10.2

156

XKC03

NOMESCO Finland

Water cystometry

3.6

10.2

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.2

10.1

494

S19

ICPC

Skin injury other

3.4

10.1

109

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

4.4

10.1

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

10.1

281

M45

ICD-10 Finland

Ankylosing spondylitis

4.2

10.0

A03

ICPC

Fever

2.0

10.0

127

708

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

3.1

10.0

136

N05CF02

ATC

zolpidem; oral

2.0

10.0

134

762

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.8

10.0

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.5

9.9

N06AA10

ATC

nortriptyline; systemic

3.9

9.9

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

4.1

9.9

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

26.5

9.8

QDB10, ,

SPAT

4.8

9.8

Z94.0

ICD-10 Finland

Kidney transplant status

10.8

9.8

R09

ICPC

Sinus symptom/complaint

2.4

9.7

331

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.4

9.7

107

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

13.6

9.7

J05AH02

ATC

oseltamivir; oral

13.6

9.7

R05

ICD-10 Finland

Cough

1.9

9.7

153

917

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.0

9.7

144

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

55.8

9.7

251, ,

Kela drug reimbursment

55.8

9.7

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

4.4

9.7

SPAT1139

SPAT

Nutrition survey

3.7

9.6

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.4

9.6

287

XA800

NOMESCO Finland

Neuropsychological investigation

3.1

9.6

139

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

9.6

126

710

A10BJ02

ATC

liraglutide; parenteral

3.6

9.6

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.9

9.6

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.9

9.6

N29

ICPC

Neurological sympt/complt other

4.7

9.6

RD210, ,

NOMESCO Finland

4.7

9.6

RF410, ,

NOMESCO Finland

9.3

9.6

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

9.6

202

N06AB05

ATC

paroxetine; oral

2.7

9.6

202

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

9.5

129

L16

ICPC

Ankle symptom/complaint

2.1

9.5

470

J01DA01

ATC

[U] cefalexin

1.7

9.5

413

3274

WX780

NOMESCO Finland

Remote monitoring CPAP

3.0

9.5

151

L01BB02

ATC

mercaptopurine; oral

7.7

9.5

Z01.2

ICD-10 Finland

Dental examination

1.7

9.5

314

2320

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

9.5

278

1990

A11CC03

ATC

alfacalcidol; systemic

4.3

9.4

E000006, ,

ATC

2.5

9.4

252

R42

ICD-10 Finland

Dizziness and giddiness

1.8

9.4

154

932

W17

ICD-10 Finland

Other fall from one level to another

3.5

9.4

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

17.8

9.4

RS142, ,

NOMESCO Finland

30.5

9.4

SPAT1360

SPAT

Extensive global examination

2.7

9.4

192

M03BX01

ATC

baclofen; systemic

4.5

9.4

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

8.2

9.4

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.2

9.4

120

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.6

9.3

211

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

9.3

468

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

4.3

9.2

S21

ICPC

Skin texture symptom/complaint

2.0

9.2

103

548

L52

ICD-10 Finland

Erythema nodosum

13.9

9.2

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.7

9.2

206

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

9.2

101

534

SPAT1240

SPAT

Therapeutic discussion

2.2

9.2

407

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

3.5

9.1

M04AA01

ATC

allopurinol; systemic

2.2

9.1

387

C03AA03

ATC

hydrochlorothiazide; oral

2.4

9.1

275

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.0

9.1

138

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.7

9.1

A02BX02

ATC

sucralfate; oral

3.2

9.1

117

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

10.2

9.1

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

15.9

9.1

M03BX02

ATC

tizanidine; oral

1.7

9.1

425

3418

395

Kela drug reimbursment

Dupilumab

37.2

9.0

D11AH05

ATC

dupilumab; topical

37.2

9.0

N05CD07

ATC

temazepam; oral

2.2

9.0

403

K30

ICD-10 Finland

Functional dyspepsia

2.1

9.0

459

R55

ICD-10 Finland

Syncope and collapse

2.2

9.0

369

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

9.0

233

R52.0

ICD-10 Finland

Acute pain

3.2

8.9

113

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.3

8.9

108

J01DA09

ATC

[U] cefadroxil

1.8

8.9

183

1185

N02AJ13

ATC

tramadol and paracetamol; systemic

3.9

8.9

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

8.8

ZYC01, ,

SPAT

2.3

8.8

319

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.7

8.8

187

H25.1

ICD-10 Finland

Senile nuclear cataract

1.8

8.8

161

1008

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

8.7

224

D50.8

ICD-10 Finland

Other iron deficiency anaemias

6.7

8.7

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

6.7

8.7

A12AA04

ATC

calcium carbonate; oral

6.7

8.7

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

6.7

8.7

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

8.7

218

L01XX23

ATC

mitotane; oral

50.7

8.7

E27.8

ICD-10 Finland

Other specified disorders of adrenal gland

50.7

8.7

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.0

8.7

131

C09CA01

ATC

losartan; oral

1.8

8.7

170

1084

205

Kela drug reimbursment

Chronic hypertension

1.8

8.6

155

963

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

4.9

8.6

ZX100

NOMESCO Finland

Oral

4.9

8.6

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

8.6

403

RF420, ,

NOMESCO Finland

7.1

8.6

SPAT1202

SPAT

Intra-articular injection

3.5

8.6

A12BA01

ATC

potassium chloride; oral

3.4

8.6

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.4

8.6

L04AB06

ATC

golimumab; parenteral

9.2

8.6

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

8.5

164

1039

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

27.9

8.5

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

7.5

8.5

Z93

ICD-10 Finland

Artificial opening status

20.3

8.5

R04.0

ICD-10 Finland

Epistaxis

2.5

8.5

227

104

Kela drug reimbursment

Thyroid insufficiency

2.4

8.5

246

OAB43, ,

SPAT

0.5

8.5

1298

WVA20, ,

SPAT

3.6

8.5

JAH01

NOMESCO Finland

Laparoscopy

2.8

8.4

150

D84.18

ICD-10 Finland

Other specified defect in the complement system

91.2

8.4

E24.2

ICD-10 Finland

Drug-induced Cushing syndrome

91.2

8.4

N30.9

ICD-10 Finland

Cystitis, unspecified

2.6

8.4

191

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

4.6

8.4

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

8.0

8.4

S22.3

ICD-10 Finland

Fracture of rib

2.5

8.4

228

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.7

8.4

TK800

NOMESCO Finland

Hemodialysis

4.7

8.4

XA402

NOMESCO Finland

ENMG

3.7

8.4

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.6

8.4

204

RJ630, ,

NOMESCO Finland

+∞

8.3

G72.9

ICD-10 Finland

Myopathy, unspecified

8.7

8.3

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

8.7

8.3

TKC22

NOMESCO Finland

Catheterisation instruction

4.2

8.3

R03BB07

ATC

umeclidinium bromide; inhalant

9.6

8.3

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

8.3

445

3661

WX882

NOMESCO Finland

High dependency care

3.5

8.3

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.4

8.3

G44.2

ICD-10 Finland

Tension-type headache

1.9

8.3

106

591

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.3

8.3

294

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

8.3

193

UJG02

NOMESCO Finland

Proctoscopy

4.3

8.2

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

6.6

8.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

8.2

355

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.8

8.2

158

SPAT1057

SPAT

Peak expiratory flow measurement

4.0

8.2

J20

ICD-10 Finland

Acute bronchitis

2.1

8.2

404

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.5

8.2

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.7

8.2

170

A03CA02

ATC

clidinium and psycholeptics; oral

2.7

8.2

170

J01CF05

ATC

flucloxacillin; systemic

2.6

8.2

200

N03AX11

ATC

topiramate; oral

3.5

8.2

R5120

NOMESCO Finland

Preparation of an aid

3.5

8.2

D01AE15

ATC

terbinafine; topical

2.5

8.2

225

R49.01

ICD-10 Finland

Functional dysphonia

3.1

8.2

114

XQ845

NOMESCO Finland

Dermatoscopy

4.8

8.2

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.1

8.1

405

R30.0

ICD-10 Finland

Dysuria

2.9

8.1

136

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

8.1

191

1278

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.1

8.1

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.1

8.1

XW000

NOMESCO Finland

Bone marrow biopsy

3.1

8.1

109

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

7.0

8.1

J96.0

ICD-10 Finland

Acute respiratory failure

7.0

8.1

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

11.9

8.1

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

17.4

8.1

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

17.4

8.1

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

17.4

8.1

L04AB05

ATC

certolizumab pegol; parenteral

17.4

8.1

K59.0

ICD-10 Finland

Constipation

2.6

8.1

183

K93

ICPC

Pulmonary embolism

9.1

8.1

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

10.2

8.1

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.6

8.0

M01AX01

ATC

nabumetone; oral

2.9

8.0

137

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

22.3

8.0

NDG71

NOMESCO Finland

Arthrodes of first MP joint

22.3

8.0

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

22.3

8.0

L50.0

ICD-10 Finland

Allergic urticaria

3.5

8.0

A02BA03

ATC

famotidine; systemic

3.4

8.0

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

8.0

298

H57.1

ICD-10 Finland

Ocular pain

2.8

8.0

143

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

7.4

8.0

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.8

8.0

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.3

8.0

299

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

7.9

191

C08CA13

ATC

lercanidipine; oral

2.0

7.9

525

I50.0

ICD-10 Finland

Congestive heart failure

2.6

7.9

179

N06AB10

ATC

escitalopram; oral

1.8

7.9

147

921

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

7.9

375

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.1

7.9

111

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

7.9

119

700

J05AB11

ATC

valaciclovir; oral

1.9

7.8

112

647

J01DA08

ATC

[U] cefaclor

2.1

7.8

383

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

11.0

7.8

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

7.1

7.8

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

7.1

7.8

HAHOM, ,

NOMESCO Finland

7.1

7.8

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

9.6

7.8

N06AB06

ATC

sertraline; oral

2.0

7.8

470

SPAT1059

SPAT

Spirometry at the office

2.7

7.8

163

S06

ICPC

Rash localized

2.7

7.8

163

J01DC02

ATC

cefuroxime; systemic

2.6

7.7

181

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.6

7.7

175

M05BA01

ATC

etidronic acid; systemic

15.2

7.7

N18.8

ICD-10 Finland

Other chronic renal failure

4.4

7.7

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

7.7

194

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.4

7.7

219

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.1

7.7

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

4.1

7.7

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.6

7.7

176

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

7.6

539

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

8.2

7.6

Z2446

NOMESCO Finland

Social worker

2.3

7.6

258

SBB10

NOMESCO Finland

Dental impressions

2.3

7.6

265

XG466

NOMESCO Finland

Sleep oxymetry

3.5

7.6

ZXC50

NOMESCO Finland

Cryotherapy

3.4

7.6

L30.3

ICD-10 Finland

Infective dermatitis

3.0

7.6

119

J33.8

ICD-10 Finland

Other polyp of sinus

4.2

7.6

J01.1

ICD-10 Finland

Acute frontal sinusitis

4.2

7.6

M79.1

ICD-10 Finland

Myalgia

1.9

7.6

109

631

SPAT1304

SPAT

Counselling and guidance related to ageing

2.4

7.6

214

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

10.2

7.6

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

10.2

7.6

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

7.5

168

1106

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.3

7.5

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

7.2

7.5

R13

ICD-10 Finland

Dysphagia

2.3

7.5

247

J37.0

ICD-10 Finland

Chronic laryngitis

3.0

7.5

109

M02AA07

ATC

piroxicam; topical

1.6

7.5

233

1670

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.4

7.5

XF404

NOMESCO Finland

Ambulatory ECG

2.2

7.4

301

G43.3

ICD-10 Finland

Complicated migraine

3.8

7.4

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.8

7.4

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

13.5

7.4

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

13.5

7.4

Z01.9

ICD-10 Finland

Special examination, unspecified

2.4

7.4

229

E86

ICD-10 Finland

Volume depletion

4.1

7.4

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

7.4

392

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.3

7.4

249

WYA10

NOMESCO Finland

Emergency care or similar visit

2.2

7.4

282

A01AB10

ATC

natamycin; local oral

3.2

7.3

R5599

NOMESCO Finland

Other rehabilitation service

3.2

7.3

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.7

7.3

156

L08

ICPC

Shoulder symptom/complaint

1.7

7.3

150

964

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.3

7.3

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.9

7.3

116

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

7.3

161

1056

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.3

7.3

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

6.3

7.3

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.8

7.3

139

Z2445

NOMESCO Finland

Psychologist

2.8

7.3

139

-50

ICPC

Medication/prescr/renewal

2.9

7.3

122

N06AX12

ATC

bupropion; oral

2.3

7.3

244

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.3

7.3

244

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.7

7.2

151

S86.0

ICD-10 Finland

Injury of Achilles tendon

3.8

7.2

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

7.2

225

TQW99

NOMESCO Finland

Other minor procedure on skin

2.6

7.2

163

R06.5

ICD-10 Finland

Mouth breathing

2.2

7.2

318

RF120, ,

NOMESCO Finland

7.4

7.2

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

4.6

7.2

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

3.0

7.2

106

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.8

7.2

134

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

7.2

245

C05AA08

ATC

fluocortolone; rectal, topical

1.9

7.2

542

L19

ICPC

Muscle symptom/complaint NOS

3.5

7.2

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.5

7.2

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.1

7.2

101

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

30.4

7.2

M04AA03

ATC

febuxostat; oral

30.4

7.2

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

30.4

7.2

L26

ICD-10 Finland

Exfoliative dermatitis

30.4

7.2

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

20.3

7.1

WX730

NOMESCO Finland

Conventional respirator

6.7

7.1

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

4.1

7.1

J01CA08

ATC

pivmecillinam; oral

1.6

7.1

276

2076

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.2

7.1

286

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

5.7

7.1

A10BK03

ATC

empagliflozin; oral

2.1

7.1

369

D07XC01

ATC

betamethasone; topical

2.0

7.1

441

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.5

7.1

177

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

8.9

7.1

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

8.9

7.1

R06AX18

ATC

acrivastine; oral

3.2

7.1

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

7.1

427

D94

ICPC

Chronic enteritis/ulcerative colitis

10.2

7.1

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.6

7.0

K07

ICPC

Swollen ankles/oedema

2.8

7.0

130

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

7.1

7.0

K63.5

ICD-10 Finland

Polyp of colon

3.9

7.0

NH1AD

NOMESCO Finland

Ankle and foot CT

3.9

7.0

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.2

7.0

281

E66.9

ICD-10 Finland

Obesity, unspecified

2.9

7.0

119

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

4.4

7.0

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.4

7.0

EMAK, ,

NOMESCO Finland

3.0

7.0

108

B01AC04

ATC

clopidogrel; oral

1.9

7.0

555

M54.1

ICD-10 Finland

Radiculopathy

2.8

7.0

125

SPAT1058

SPAT

PEF monitoring instruction

2.2

6.9

282

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.8

6.9

131

A41.8

ICD-10 Finland

Other specified sepsis

4.0

6.9

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

6.9

149

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

6.9

198

R04.2

ICD-10 Finland

Haemoptysis

3.3

6.9

A10BA02

ATC

metformin; oral

1.6

6.9

176

1197

L50.9

ICD-10 Finland

Urticaria, unspecified

2.8

6.9

126

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.1

6.8

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

6.8

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.7

6.8

132

A50

ICPC

General and Unspecified, Medication/prescr/renewal

3.0

6.8

104

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

6.8

164

1098

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

11.1

6.8

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

6.8

144

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

6.2

6.8

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.3

6.8

251

XG405

NOMESCO Finland

Education on PEF monitoring

5.8

6.8

N06AX18

ATC

reboxetine; oral

5.8

6.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

6.8

225

W19

ICD-10 Finland

Unspecified fall

2.1

6.8

333

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

40.5

6.8

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

40.5

6.8

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

40.5

6.8

8370/3-C74.0

ICD-O-3

Adrenal cortical carcinoma of cortex of adrenal gland

40.5

6.8

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.6

6.8

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

6.7

110

661

R95

ICPC

Chron obstructive pulmonary disease

3.5

6.7

R41.0

ICD-10 Finland

Disorientation, unspecified

3.4

6.7

L01

ICPC

Neck symptom/complaint

1.8

6.7

111

669

H53.2

ICD-10 Finland

Diplopia

3.1

6.7

U04

ICPC

Incontinence urine

2.6

6.7

157

E27.0

ICD-10 Finland

Other adrenocortical overactivity

22.8

6.7

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

4.1

6.7

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

3.2

6.7

R01AC02

ATC

levocabastine; nasal

3.2

6.7

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

7.9

6.6

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

7.9

6.6

J05AB01

ATC

aciclovir; systemic

1.7

6.6

153

1013

B02.9

ICD-10 Finland

Zoster without complication

2.3

6.6

221

M54.3

ICD-10 Finland

Sciatica

2.3

6.6

221

SFA10

NOMESCO Finland

One-surface restoration

1.5

6.6

359

2891

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

3.4

6.6

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.8

6.6

123

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

12.4

6.6

J01FA01

ATC

erythromycin; systemic

1.9

6.6

504

J01CE08

ATC

benzathine benzylpenicillin; parenteral

8.8

6.6

WX212

NOMESCO Finland

Femoral plexus blockade

3.9

6.6

B34.9

ICD-10 Finland

Viral infection, unspecified

3.1

6.6

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.9

6.6

112

R01AC07

ATC

nedocromil; nasal

10.2

6.6

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

10.2

6.6

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

10.2

6.6

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.0

6.6

101

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

6.9

6.5

R4120

NOMESCO Finland

Occupational therapy

2.2

6.5

242

H26.02

ICD-10 Finland

Presenil cataract

3.1

6.5

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.7

6.5

S81.0

ICD-10 Finland

Open wound of knee

5.4

6.5

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

6.3

6.5

WX720

NOMESCO Finland

Own respiration

2.5

6.5

160

C08CA02

ATC

felodipine; oral

2.2

6.5

277

N19

ICD-10 Finland

Unspecified kidney failure

3.1

6.5

J01GB01

ATC

tobramycin; inhalant, parenteral

70.5

6.4

R75

ICPC

Sinusitis acute/chronic

2.5

6.4

173

134

Kela drug reimbursment

General erythroderma

14.5

6.4

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

14.5

6.4

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

6.4

471

4039

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.2

6.4

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.4

6.4

180

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

6.6

6.4

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

8.3

6.4

G62.8

ICD-10 Finland

Other specified polyneuropathies

8.3

6.4

L20.0

ICD-10 Finland

Besnier prurigo

2.2

6.3

272

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

6.3

356

2878

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

5.6

6.3

R52.1

ICD-10 Finland

Chronic intractable pain

6.0

6.3

A10BJ05

ATC

dulaglutide; parenteral

3.5

6.3

Z50.1

ICD-10 Finland

Other physical therapy

2.5

6.3

168

U07

ICPC

Urine symptom/complaint other

2.2

6.3

259

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

11.2

6.3

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

11.2

6.3

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

11.2

6.3

A02BB01

ATC

misoprostol; oral

9.4

6.3

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.2

6.3

246

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.1

6.3

256, ,

Kela drug reimbursment

18.2

6.3

HMAK, ,

NOMESCO Finland

1.9

6.3

460

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.1

6.3

ZXD00

NOMESCO Finland

Emergency procedure

3.1

6.3

-1, ,

NOMESCO Finland

1.5

6.2

222

1627

288

Kela drug reimbursment

Febuxostat

26.9

6.2

349

Kela drug reimbursment

Febuxostat

26.9

6.2

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

2.9

6.2

104

P03

ICPC

Feeling depressed

2.0

6.2

351

SPAT1285

SPAT

Provision of consultation response

2.5

6.2

157

R10.0

ICD-10 Finland

Acute abdomen

3.2

6.2

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.1

6.2

N62

ICD-10 Finland

Hypertrophy of breast

2.6

6.2

139

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.6

6.2

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

4.0

6.2

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

6.2

317

N05BA12

ATC

alprazolam; oral

2.0

6.1

389

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

6.1

N03AF02

ATC

oxcarbazepine; oral

2.8

6.1

105

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.8

6.1

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.8

6.1

A29

ICPC

General symptom/complaint other

1.8

6.1

501

R07.2

ICD-10 Finland

Precordial pain

4.2

6.1

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

12.7

6.1

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.7

6.1

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.7

6.1

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

3.7

6.1

QDA10

NOMESCO Finland

Incision of skin of lower limb

8.7

6.1

K08.3

ICD-10 Finland

Retained dental root

2.2

6.1

243

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

6.8

6.1

D05BB02

ATC

acitretin; oral

3.5

6.0

S91.3

ICD-10 Finland

Open wound of other parts of foot

3.3

6.0

M75.5

ICD-10 Finland

Bursitis of shoulder

3.3

6.0

L04AC05

ATC

ustekinumab; parenteral

10.1

6.0

WX308

NOMESCO Finland

Sacral anesthesy

10.1

6.0

A10BK01

ATC

dapagliflozin; oral

2.2

6.0

230

S20.2

ICD-10 Finland

Contusion of thorax

2.5

6.0

147

H26.2

ICD-10 Finland

Complicated cataract

5.3

6.0

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

5.3

6.0

G51.0

ICD-10 Finland

Bell palsy

3.4

6.0

SPAT1359

SPAT

Use of symptom diary

3.4

6.0

S76

ICPC

Skin infection other

2.4

6.0

172

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

6.1

6.0

F61.0

ICD-10 Finland

Mixed personality disorders

3.9

6.0

SXC05

NOMESCO Finland

Other oral or dental procedure

2.2

6.0

244

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3036481) Cortisol [Moles/volume] in Serum or Plasma

543

533

51.76

307.65

6.7

2.1

175.27

366.19

nmol/l

55.92

521

495

(3035637) Corticotropin [Mass/volume] in Plasma

186

36.02

280.23

2.2

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

272

458

9.37

169.85

7.0

4.4

0.88

1.05

0.46

117

169

(3002179) Metamyelocytes/100 leukocytes in Blood

259

419

9.50

167.12

6.2

4.4

0.48

0.60

0.48

107

143

(3025159) Blasts/100 leukocytes in Blood

253

408

9.41

163.36

7.2

4.6

0.03

0.15

0.77

118

(3021440) Promyelocytes/100 leukocytes in Blood

255

428

9.06

158.66

7.2

4.6

0.10

0.13

0.25

100

139

(3011985) Renin [Units/volume] in Plasma

113

19.54

137.82

2.7

1.2

84.39

44.14

mu/l

0.58

100

(3005719) IgG [Mass/volume] in Serum or Plasma

235

445

7.63

128.55

5.0

2.8

9.25

10.25

g/l

2.76

221

419

(3005322) IgE [Units/volume] in Serum or Plasma

210

388

7.46

116.65

2.5

1.2

488.75

187.54

u/ml

0.88

199

359

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

116

104

13.31

113.77

4.8

3.7

59.98

57.17

0.88

116

104

(40760892) CBC W Ordered Manual Differential panel - Blood

568

2648

8.99

112.09

19.8

6.4

—

(3023368) Bacteria identified in Blood by Culture

397

1372

5.72

110.37

8.4

4.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

112

101

13.14

109.32

4.4

3.3

5.02

4.41

e9/l

1.15

112

101

(3001604) Monocytes [#/volume] in Blood

569

2810

8.23

100.37

15.7

5.9

0.67

0.57

e9/l

15.91

554

2429

(3006315) Basophils [#/volume] in Blood

569

2816

8.20

99.93

15.7

5.9

0.04

e9/l

2.41

554

2438

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

205

427

6.50

99.85

6.7

3.8

1.22

1.23

mmol/l

1.12

196

371

(3013115) Eosinophils [#/volume] in Blood

578

2921

8.63

98.56

16.2

6.1

0.18

0.19

e9/l

0.68

561

2564

(3028026) IgM [Mass/volume] in Serum or Plasma

185

360

6.74

96.32

2.4

1.7

1.06

1.36

g/l

1.84

176

335

(3019198) Lymphocytes [#/volume] in Blood

570

2884

7.96

95.76

15.9

5.9

1.88

1.96

e9/l

0.80

555

2558

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

184

381

6.30

89.42

2.7

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

537

2699

6.21

87.10

14.8

7.0

1.21

1.22

mmol/l

1.43

418

2321

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

498

2357

5.47

87.03

4.4

2.3

80.83

76.26

nmol/l

3.35

483

2133

(4062490) Immunoglobulin typing, IgG

16.79

86.65

2.1

1.4

—

(3023419) Bacteria identified in Sputum by Culture

12.85

85.39

5.3

2.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

486

2289

5.21

84.53

10.8

4.9

34.06

35.81

g/l

10.35

466

2144

(3022096) Basophils/100 leukocytes in Blood

518

2569

5.65

84.19

16.3

5.9

0.62

0.69

1.81

512

2397

(3027135) IgG subclass 1 [Mass/volume] in Serum

16.62

83.99

1.9

1.4

6.12

6.36

g/l

0.14

(3024139) IgG subclass 3 [Mass/volume] in Serum

16.62

83.99

1.9

1.4

0.36

0.32

g/l

0.28

(3028192) IgG subclass 2 [Mass/volume] in Serum

16.62

83.99

1.9

1.4

2.36

2.63

g/l

0.37

(1616796) Gas panel - Central venous blood

109

10.50

83.76

5.8

3.3

—

(3006504) Eosinophils/100 leukocytes in Blood

523

2655

5.59

81.34

16.5

5.9

2.42

2.90

5.10

515

2486

(3019069) Monocytes/100 leukocytes in Blood

524

2671

5.59

80.87

17.0

6.2

8.57

8.45

0.48

518

2506

(3013650) Neutrophils [#/volume] in Blood by Automated count

584

3265

7.62

80.26

19.6

9.2

5.01

4.05

e9/l

18.41

567

2856

(3012095) Magnesium [Moles/volume] in Serum or Plasma

272

863

4.65

79.05

5.9

3.9

0.81

0.82

mmol/l

0.32

262

816

(3024980) IgG subclass 4 [Mass/volume] in Serum

11.74

78.75

1.9

2.0

0.46

0.85

g/l

1.06

(3015171) Extractable nuclear Ab [Units/volume] in Serum

135

233

7.02

78.15

1.4

1.2

1.72

1.79

u/ml

0.01

(3002030) Lymphocytes/100 leukocytes in Blood

525

2736

5.41

77.16

16.7

6.0

24.99

28.68

12.33

517

2577

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

266

848

4.57

76.45

3.3

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

204

527

5.15

76.40

6.4

3.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

399

1711

4.35

76.22

5.0

2.4

54.55

62.69

u/l

0.85

381

1579

(40767503) Oxygen content in Capillary blood by calculation

110

9.79

75.81

4.4

2.3

16.23

16.20

0.02

(3004789) Transferrin [Mass/volume] in Serum or Plasma

251

772

4.62

75.47

3.4

2.4

2.37

2.36

g/l

0.17

237

718

(3018418) pH of Serum or Plasma

382

1604

4.26

74.78

7.4

3.8

7.40

0.49

166

299

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

241

723

4.67

74.75

3.5

2.4

20.71

22.63

1.09

203

624

(3007853) Bacteria identified in Skin by Aerobe culture

223

631

4.82

74.49

3.0

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

517

2709

5.13

74.14

15.7

5.8

61.27

56.59

15.67

510

2550

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

339

1319

4.21

73.68

3.9

2.1

3.52

3.02

mg/l

3.17

314

1138

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

15.91

73.39

2.0

1.1

1.54

1.15

u/ml

0.15

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

485

2456

4.63

71.94

14.4

6.5

1.20

1.22

mmol/l

4.35

471

2252

(3012501) Base excess in Blood by calculation

103

9.70

70.84

7.5

3.2

2.68

2.27

mmol/l

0.63

(3022948) Iron [Moles/volume] in Serum or Plasma

258

845

4.36

70.73

3.6

2.4

11.31

13.09

umol/l

3.53

243

787

(3009445) Proteinase 3 Ab [Units/volume] in Serum

128

241

6.34

67.55

1.8

1.5

2.60

8.40

u/ml

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

143

7.96

67.06

2.4

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

550

3164

5.33

66.04

11.6

5.0

6.56

6.65

mmol/l

0.49

539

2970

(3022217) INR in Platelet poor plasma by Coagulation assay

467

2393

4.22

65.79

23.5

12.5

1.21

inr

0.04

226

697

(3019060) Gas panel - Arterial blood

146

325

5.48

64.21

6.3

6.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

15.04

63.76

2.0

2.1

—

(3026782) Osmolality of Urine

285

1074

3.90

62.88

5.1

2.8

480.26

534.90

mosm/kgh2o

4.00

268

929

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

147

7.56

62.86

2.4

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

105

8.89

62.70

1.7

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

342

1461

3.77

62.38

8.0

3.8

0.00

estimate

0.80

202

510

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

110

196

6.53

61.12

3.0

1.9

1.07

3.30

ug/l

0.85

102

178

(3037522) Nuclear Ab [Titer] in Serum

238

809

4.03

60.67

1.7

1.3

481.51

492.96

titre

0.03

179

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

9.88

60.40

2.2

1.6

—

(3021589) Normoblasts [#/volume] in Blood

474

2542

4.03

60.33

28.7

9.1

0.00

0.01

e9/l

0.55

452

2074

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

200

603

4.32

60.16

2.9

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

512

2897

4.37

60.13

11.0

6.3

9.33

11.72

umol/l

5.93

499

2752

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

147

7.29

59.10

2.8

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

199

607

4.26

58.78

3.0

1.9

—

(40761536) Microorganisms panel - Urine sediment

171

469

4.57

58.08

8.0

3.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

386

1843

3.62

58.08

5.0

3.4

2.32

2.36

mmol/l

5.45

358

1645

(3021387) Prolactin [Units/volume] in Serum or Plasma

104

190

6.31

56.19

1.8

1.4

340.75

272.15

mu/l

2.22

175

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

8.99

56.16

2.2

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

341

1531

3.53

56.08

7.1

3.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

418

2132

3.60

55.93

7.9

3.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

329

1448

3.53

55.79

5.1

3.2

1195.06

1033.34

ng/l

0.21

294

1233

(3021901) Oxygen saturation in Capillary blood

106

8.21

55.40

3.4

3.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

9.13

55.37

2.0

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

14.46

55.05

2.1

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

486

2749

3.88

54.77

7.5

3.6

0.00

estimate

0.50

208

552

(3003458) Phosphate [Moles/volume] in Serum or Plasma

215

725

3.91

54.73

10.0

6.0

1.05

1.06

mmol/l

0.31

206

671

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

279

1119

3.58

54.60

2.1

1.7

27615518.49

29325332.21

pmol/l

0.02

239

948

(3042936) Bacteria identified in Isolate by Culture

225

785

3.82

54.45

3.3

2.0

—

(3000850) Epithelial cells [#/volume] in Urine

279

1123

3.56

54.23

4.8

2.6

5.87

6.25

e6/l

0.14

267

1015

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

8.09

54.07

2.3

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

106

7.97

52.75

1.9

1.8

—

(3011412) CD3 cells [#/volume] in Blood

10.70

52.32

1.6

2.0

1.34

1.23

e9/l

0.24

(3021601) Nitrite [Presence] in Urine by Test strip

483

2767

3.75

52.31

9.2

4.8

0.00

estimate

-0.00

206

519

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

101

193

5.99

51.97

2.4

1.6

322.67

193.33

titre

—

(3009261) Glucose [Presence] in Urine by Test strip

485

2794

3.74

51.87

7.5

3.5

0.00

0.01

estimate

0.80

203

500

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

7.96

51.42

7.0

7.8

232.82

206.63

iu/ml

0.07

(3025941) Bacteria identified in Stool by Culture

133

328

4.82

51.21

1.6

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

445

2458

3.46

50.31

4.9

2.8

131.62

111.52

ug/l

1.07

425

2286

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

155

6.48

50.28

3.3

2.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

619

4292

7.66

49.76

19.5

7.3

78.25

79.95

u/l

0.49

614

4035

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

9.60

49.14

2.0

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

151

425

4.31

48.97

2.6

64.13

66.91

g/l

3.65

141

391

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

137

359

4.55

48.76

4.6

3.3

4.36

4.50

pmol/l

0.92

125

316

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

177

561

3.94

48.69

5.3

4.4

287.63

243.78

u/l

0.68

169

532

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

388

2007

3.25

48.35

7.4

3.5

25.90

38.98

ng/l

1.91

319

1352

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

16.74

48.13

2.0

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

337

1612

3.22

47.96

3.4

2.1

178.47

231.44

u/l

0.48

323

1531

(3009214) Lutropin [Units/volume] in Serum or Plasma

142

6.54

47.65

1.5

1.4

14.34

11.01

u/l

0.85

116

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

14.21

47.21

2.0

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

16.12

47.20

2.0

1.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

176

571

3.83

46.62

8.6

9.4

10.97

12.50

kpa

4.63

171

554

(3042631) Mycobacterium sp identified in Specimen

9.50

46.42

4.6

2.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

109

7.29

46.36

3.4

2.8

—

(3003396) Base excess in Arterial blood by calculation

175

573

3.79

45.65

8.7

9.4

1.61

1.19

mmol/l

0.89

149

470

(3030313) Adrenal Ab [Titer] in Serum

105.67

45.44

1.1

1.0

—

(3002582) Erythrocytes [#/volume] in Urine

334

1640

3.09

44.56

5.5

3.2

95.53

95.25

e6/l

0.00

296

1258

(3013707) Erythrocyte sedimentation rate by Westergren method

599

4175

5.50

44.37

12.5

4.1

14.49

11.80

mm/h

5.13

582

3868

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

278

1256

3.09

42.58

3.2

1.9

1.28

1.14

mg/l

0.26

223

973

(3007164) IgA [Mass/volume] in Serum or Plasma

268

1190

3.10

42.26

2.3

1.4

2.47

2.34

g/l

0.45

219

716

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

9.32

41.91

1.7

1.8

31.44

33.15

1.46

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

132

378

4.11

41.38

8.8

5.6

2.59

1.67

mmol/l

2.53

104

289

(3026008) Bacteria identified in Urine by Culture

332

1677

2.96

41.23

4.9

2.8

—

(3000012) Reticulocyte production index

8.91

41.23

1.8

2.0

—

(3030467) Casts [#/volume] in Urine by Automated count

307

1492

2.97

40.85

5.1

3.1

0.22

0.44

e6/l

2.28

277

1116

(3004588) Protein electrophoresis panel - Serum or Plasma

128

363

4.13

40.63

2.4

2.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

144

5.83

39.15

1.7

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

101

246

4.66

39.02

3.2

2.2

34.72

39.37

u/l

1.54

220

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

7.75

38.70

1.9

1.6

—

(3009343) pH of Capillary blood

131

394

3.90

38.16

9.1

5.5

7.44

7.41

2.69

(3021960) Folate [Moles/volume] in Serum or Plasma

264

1234

2.89

36.99

1.7

1.5

21.98

21.33

nmol/l

0.22

239

1055

(3027945) Reticulocytes/100 erythrocytes in Blood

164

587

3.38

36.58

3.9

2.7

1.89

1.79

0.73

146

535

(3000494) Fungus identified in Specimen by Culture

182

699

3.21

36.09

2.2

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

133

423

3.68

35.56

3.0

2.7

73.22

72.89

e9/l

0.03

112

319

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

149

511

3.47

35.48

3.2

2.3

0.23

0.21

g/l

1.86

138

485

(3031040) Bacteria [#/volume] in Urine by Automated count

531

3629

3.33

35.31

8.8

4.2

207.00

2527.11

e6/l

1.08

(3018095) Leukocytes [#/volume] in Urine

352

1944

2.73

35.24

6.3

3.7

48.63

74.85

e6/l

0.69

307

1358

(36304419) Bacteria [Presence] in Urine

292

1470

2.76

35.10

5.2

3.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

177

5.00

34.59

1.8

1.6

0.01

0.11

iu/ml

0.90

(3019309) Folate [Moles/volume] in Red Blood Cells

213

927

2.91

33.56

2.1

1.7

1516.15

1201.41

nmol/l

4.32

156

701

(3037467) Urinalysis macro (dipstick) panel - Urine

544

3826

3.35

33.26

9.2

4.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

337

1860

2.65

33.20

6.3

3.4

31.89

31.23

u/l

0.13

314

1776

(3003181) Sodium [Moles/volume] in Urine

6.57

32.75

1.9

1.6

75.31

66.45

mmol/l

0.61

(3048689) Calprotectin [Mass/mass] in Stool

177

716

3.01

31.64

5.2

2.3

245.95

119.88

ug/g

1.92

157

574

(3002032) Base excess in Venous blood by calculation

142

511

3.26

30.99

12.3

4.5

2.58

1.85

mmol/l

1.85

132

421

(3018677) aPTT in Platelet poor plasma by Coagulation assay

190

808

2.89

30.93

3.5

2.5

29.54

29.72

0.15

182

791

(3004809) Band form neutrophils/100 leukocytes in Blood

6.65

30.85

3.2

3.4

1.00

1.21

0.24

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

54.23

30.63

1.2

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

115

5.64

30.40

2.1

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

163

648

3.01

29.89

10.8

7.4

103.34

104.38

mmol/l

1.84

163

648

(3026493) Urate [Moles/volume] in Serum or Plasma

270

1398

2.57

29.53

4.0

2.5

3996.19

6413.77

umol/l

0.47

236

1232

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

201

4.39

29.47

1.7

1.6

0.25

0.24

g/l

0.42

194

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

213

4.25

28.91

1.7

1.5

1.29

1.19

g/l

1.84

206

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

103

316

3.68

28.75

2.0

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

9.38

27.93

1.2

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

121

5.25

27.72

4.4

4.0

—

(3015736) pH of Urine

365

2228

2.42

27.21

5.7

3.4

5.83

5.88

0.07

192

(3047181) Lactate [Moles/volume] in Blood

156

4.67

27.11

8.4

9.3

1.43

1.30

mmol/l

0.47

140

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.16

27.01

5.1

4.4

88612.83

3130.78

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

6.38

25.78

1.5

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

150

614

2.86

25.74

1.8

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

7.81

24.83

1.7

2.0

491.96

515.84

e6/l

0.08

(21494815) CD4 cells/100 lymphocytes in Specimen

7.56

24.81

1.4

1.9

47.38

35.49

3.71

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

6.69

24.62

2.1

1.5

59.25

60.21

0.04

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

7.91

24.41

1.7

2.0

0.23

0.22

e9/l

0.06

(3022145) Colonoscopy Study observation

150

631

2.78

24.33

1.8

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

572

4425

3.13

24.07

7.7

4.1

15.11

14.67

pmol/l

3.55

549

4049

(46235355) HIV 1 and 2 tests - Meaningful Use set

194

941

2.50

23.47

2.0

1.8

—

(3020891) Body temperature

208

3.88

23.31

7.2

5.5

—

(3008295) Osmolality of Serum or Plasma

6.82

23.23

1.4

1.5

275.43

282.50

mosm/kgh2o

0.88

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

209

1054

2.44

23.19

1.6

1.3

18.00

34.23

iu/ml

3.82

344

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

5.68

22.41

1.6

1.4

0.39

0.29

nmol/l

0.56

(3044889) 12 lead EKG panel

519

3876

2.56

22.39

6.4

3.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

341

2142

2.22

22.23

2.3

2.0

91.27

96.37

pmol/l

1.43

219

1110

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

168

4.11

22.13

2.6

2.1

211.97

529.76

ug/l

0.59

155

(40768443) Skin Pathology biopsy report

231

3.64

22.05

1.6

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

207

3.78

21.94

2.1

1.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

6.24

21.91

1.7

1.3

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

5.85

21.57

1.6

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

166

776

2.52

21.52

1.8

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

163

4.09

21.39

4.2

3.6

34.28

88.81

mg/l

0.75

130

(3004451) EKG impression Narrative

8.98

20.78

1.5

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

163

4.02

20.57

4.3

3.6

27.44

30.07

mg/l

0.14

128

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

20.88

20.54

7.7

4.4

—

(3000991) Gas panel - Venous blood

113

445

2.86

20.54

14.3

9.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

198

1023

2.33

20.42

1.5

1.3

10.13

12.53

u/ml

0.21

395

(3037756) Immunofixation for Serum or Plasma

108

4.71

20.18

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

175

3.87

20.13

1.7

1.4

270.69

309.96

ug/g

0.66

102

(40768797) Stomach Pathology biopsy report

166

798

2.44

20.12

1.5

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

6.87

19.73

1.3

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

161

3.92

19.32

4.3

3.5

1.32

1.96

ratio

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

285

3.19

19.15

1.7

1.4

30.27

29.52

iu/l

0.06

242

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

110

443

2.78

19.10

5.2

3.7

82.81

75.99

ng/l

0.32

398

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

6.42

19.08

1.5

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

105

4.63

19.00

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

6.15

18.87

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

7.26

18.78

2.4

1.4

27.91

36.15

0.45

(3017446) Testosterone [Moles/volume] in Serum or Plasma

341

2.97

18.59

2.7

2.2

11.82

12.76

nmol/l

0.46

313

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

4.75

17.99

1.5

120.00

107.18

u/ml

0.37

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

111

4.38

17.72

2.7

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

111

4.38

17.72

2.7

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

183

969

2.23

17.43

3.9

2.9

2.45

mmol/l

0.27

165

858

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

390

2.78

17.33

6.9

3.8

126.90

192.68

ng/l

1.01

355

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

135

634

2.42

16.97

4.3

3.0

6.02

7.50

umol/l

0.61

111

549

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

277

3.06

16.95

12.2

12.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

643

5620

5.78

16.92

49.2

13.4

18.11

21.97

mg/l

4.33

613

4400

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

374

2605

2.00

16.75

3.9

2.5

—

(3013512) EKG study

255

1554

2.04

16.69

6.2

3.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

16.85

16.66

1.5

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

4.80

16.54

2.9

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

4.80

16.54

2.9

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

259

3.09

16.48

10.2

3.8

1.41

1.26

0.53

259

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

4.49

16.40

1.3

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

101

4.37

16.25

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

227

1343

2.05

15.99

1.5

1.3

1.32

1.58

u/ml

0.19

108

346

(21494814) CD8 cells/100 lymphocytes in Specimen

14.98

15.95

1.5

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

135

3.84

15.81

4.0

7.0

0.33

0.34

u/ml

0.11

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

611

5214

3.19

15.71

8.6

4.8

1.86

2.12

mu/l

0.57

585

4804

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

6.62

15.47

2.6

40.45

41.58

0.08

(3048929) Epstein Barr virus Ab [Presence] in Serum

169

3.46

15.11

1.7

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

105

4.10

14.62

1.7

1.4

—

(4035726) Immunohistochemistry procedure

108

489

2.44

14.58

1.6

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

399

2.58

14.55

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

643

5720

5.11

14.28

49.2

15.2

139.31

139.71

mmol/l

3.19

638

5577

(3007566) Smooth muscle Ab [Titer] in Serum

145

3.57

14.25

1.4

1.2

221.25

60.71

titre

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

644

5739

5.26

14.18

49.4

15.3

3.89

3.96

mmol/l

9.34

639

5590

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

5.72

13.93

1.3

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

100

4.08

13.88

1.8

1.4

329.84

256.67

u/ml

0.49

(3016650) Hepatitis A virus Ab [Presence] in Serum

4.14

13.79

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

477

3755

1.96

13.44

6.2

3.1

60.89

45.44

u/l

4.45

443

3535

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

142

3.49

13.25

2.0

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

428

2.42

12.91

1.3

1.2

83.62

155.17

iu/ml

1.72

183

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

291

2.70

12.77

14.3

4.8

25.18

24.13

mmol/l

2.20

284

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

211

2.92

12.03

1.8

2.1

1.71

1.49

g/l

0.66

188

(4200892) Spirometry reversibility

415

2.35

11.57

1.8

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

251

1677

1.80

11.43

4.2

3.1

7.05

7.44

mmol/l

0.65

218

1425

(3012516) Albumin [Mass/volume] in Urine

234

1534

1.81

11.34

4.0

3.2

849.93

279.06

mg/l

0.66

153

980

(3019150) Specific gravity of Urine by Refractometry

194

1206

1.86

11.13

7.7

3.8

1.01

1.02

kg/l

0.71

165

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

3.80

11.09

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

128

3.35

11.00

1.6

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

4.23

10.98

1.8

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

188

2.92

10.91

4.2

4.6

99.25

90.44

1.53

180

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

5.26

10.85

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

5.26

10.85

1.5

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

3.97

10.77

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

4.26

10.71

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

5.14

10.58

1.5

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

456

3682

1.76

10.16

3.9

3.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

11.53

10.10

1.2

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

9.34

10.07

1.2

1.5

144.47

168.65

nmol/l

0.60

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

4.16

10.05

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

12.43

9.89

3.8

4.8

43.12

50.75

0.39

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

8.30

9.89

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

8.93

9.84

2.4

1.8

82.78

59.97

ug/l

0.63

(3034891) Synovial lining cells/100 cells in Synovial fluid

8.93

9.84

2.2

1.3

1.50

1.86

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

10.24

9.56

1.5

1.7

178.36

70.44

nmol/24h

0.55

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

583

5121

2.15

9.56

8.5

5.5

41.42

39.58

mmol/mol

4.71

561

4789

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

3.98

9.49

1.1

—

(40761511) CBC panel - Blood by Automated count

640

5871

3.60

9.43

43.4

12.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

7.60

8.98

2.0

2.6

31.60

31.56

umol/l

0.00

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.96

8.76

2.0

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

446

2.09

8.58

3.6

2.4

57.23

68.62

ml/min/173m2

1.75

181

(3020682) Albumin/Creatinine [Ratio] in Urine

232

1618

1.67

8.51

4.6

3.8

15.99

10.21

mg/mmol

0.35

152

1002

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

159

1002

1.77

8.43

6.9

3.8

105.82

383.90

ng/l

2.11

114

744

(3010375) cycloSPORINE [Mass/volume] in Blood

8.01

8.41

27.9

29.7

137.83

117.44

ug/l

0.39

(3017569) Oxygen content in Arterial blood

8.01

8.41

2.4

4.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

210

2.55

8.36

1.9

1.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

8.35

6.8

0.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

544

0.21

8.28

1.6

1.7

—

(44813793) Dust mix specific IgE antibody measurement

4.63

8.16

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

371

2.15

8.11

1.4

1.3

66.53

33.64

au/ml

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

22.33

8.03

1.0

1.8

—

(3017704) Immunofixation for Urine

6.71

7.93

2.3

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

6.71

7.93

1.1

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

13.23

7.90

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

122

2.97

7.86

1.4

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

204

2.51

7.86

2.9

2.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

9.56

7.81

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

15.24

7.73

1.2

1.0

—

(3019977) pH of Arterial blood

6.82

7.63

3.1

4.9

7.43

7.44

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

3.47

7.59

1.8

1.2

28.22

62.78

u/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.35

7.46

1.0

1.2

1.57

1.58

u/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

6.08

7.42

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

586

5268

1.97

7.32

37.3

12.1

80.72

82.27

ml/min/173m2

0.94

550

4329

(3036489) Thrombin time

205

2.45

7.31

4.1

3.0

20.62

21.98

1.31

187

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

+∞

7.30

1.9

0.0

208.29

—

nmol/l

—

(3021788) Differential panel - Synovial fluid

3.15

7.24

2.0

1.5

—

(3044941) Cell count panel - Synovial fluid

3.34

7.17

1.8

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

170

2.57

7.15

1.5

1.2

28.17

2.82

u/ml

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.84

7.13

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

124

2.84

7.07

1.9

1.6

6037.04

15378.59

e6/l

1.02

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

369

0.23

6.96

1.6

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

3.77

6.96

4.3

3.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

6.20

6.81

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

6.20

6.81

1.1

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

6.53

6.67

1.1

1.2

158.06

163.75

mmol/24h

0.07

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

159

2.54

6.56

1.6

1.2

3.74

2.79

u/ml

—

(3022313) Gas panel - Capillary blood

296

2.13

6.54

12.4

5.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

161

2.51

6.39

1.6

1.2

1.62

5.71

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

4.13

6.39

1.3

1.4

—

(40768441) Liver Pathology biopsy report

4.13

6.39

1.9

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

180

2.42

6.37

1.9

2.2

0.06

0.71

g/l

2.75

162

(3018851) Theophylline [Moles/volume] in Serum or Plasma

18.22

6.28

2.2

1.6

43.67

34.40

umol/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

121

2.73

6.24

1.3

1.1

0.37

2.44

u/ml

1.64

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.73

6.23

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

291

2263

1.51

6.20

2.7

2.1

—

(40761535) Cells panel - Urine sediment

426

1.91

6.12

6.6

3.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

3.83

6.12

1.4

1.1

2.08

1.45

nmol/l

0.97

(40761539) Cells [Type] in Urine sediment by Light microscopy

8.71

6.07

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

112

2.76

6.00

1.6

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

112

2.76

6.00

1.6

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

130

2.62

5.96

1.7

1.3

7.37

172.69

e6/l

1.81

101

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

130

2.62

5.96

1.7

1.2

63.14

11.07

e6/l

0.88

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

8.12

5.86

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

8.12

5.86

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

8.12

5.86

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

8.12

5.86

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

3.08

5.85

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

156

1068

1.60

5.84

1.9

1.6

—

(40758558) Short blood count panel - Blood

201

1467

1.53

5.67

12.5

6.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

3.46

5.62

2.1

2.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

5.46

5.56

1.0

1.2

1.01

1.06

ratio

—

(21494755) Public health laboratory ask at order entry panel

571

0.36

5.54

1.3

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.53

5.48

2.3

2.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

542

1.76

5.46

3.1

4.2

11.57

28.42

ug/l

0.49

443

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

5.70

5.40

1.1

1.0

1597.50

1639.76

miu/ml

0.06

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

125

2.55

5.36

1.6

1.2

2.89

1.14

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

7.97

5.36

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

3.04

5.30

1.1

7.60

4.96

u/ml

—

(3042733) HLA Ab [Presence] in Serum

9.21

5.30

4.3

2.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.89

5.30

1.5

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

5.48

5.25

2.1

3.9

—

(3003338) MCHC [Mass/volume]

427

4821

0.68

5.16

52.3

17.4

329.85

332.12

g/l

5.12

421

4795

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

302

1.97

5.15

2.6

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

206

1540

1.49

5.10

1.8

1.7

1.80

1.38

mmol/l

5.01

162

1303

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

13.47

5.09

1.4

1.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

8.44

5.07

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

10.12

5.04

1.1

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

190

1401

1.50

5.02

7.1

4.0

93.45

92.95

0.08

177

1359

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

3.72

4.95

2.5

1.4

33.20

24.33

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

3.18

4.95

1.2

72.26

94.96

u/l

0.21

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

3.54

4.92

1.3

1.1

298.50

216.46

mg/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

150

2.34

4.88

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

652

6251

3.59

4.84

63.4

19.9

39.10

40.17

3.53

607

5894

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

585

5395

1.72

4.83

6.1

4.5

5.74

5.91

mmol/l

2.24

557

4977

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

11.55

4.79

2.8

2.6

2.01

5.14

nmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

226

1740

1.45

4.75

3.9

2.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

133

2.40

4.73

1.3

1.7

—

(3010813) Leukocytes [#/volume] in Blood

652

6256

3.54

4.73

63.1

19.8

8.04

6.63

e9/l

40.70

647

6094

(3016018) Differential panel - Cerebral spinal fluid

3.16

4.67

1.3

1.4

—

(3017732) Neutrophils [#/volume] in Blood

390

1.80

4.56

3.9

2.6

4.81

6.37

e9/l

0.51

332

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

3.32

4.49

1.3

1.1

94.67

39.02

mg/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.46

4.49

1.4

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

157

2.23

4.41

2.6

2.1

3424.47

4036.71

u/l

0.06

(3016330) Potassium [Moles/time] in 24 hour Urine

11.77

4.28

1.0

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

103

2.48

4.18

1.2

1.1

0.61

0.76

u/ml

0.12

(3014133) Dog dander IgE Ab [Units/volume] in Serum

2.68

4.10

1.2

1.0

1.75

2.54

u/ml

0.32

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

2.61

4.09

1.0

1.2

3.00

6.29

u/ml

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

2.55

4.09

1.2

1.1

10.15

138.88

iu/ml

0.92

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

419

1.72

4.08

3.0

2.4

6.84

7.85

ug/l

0.16

376

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

3.38

4.06

2.5

1.9

1.14

2.68

u/field

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

10.09

4.02

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

10.09

4.02

1.7

2.0

—

(3052851) Hemolysis interference index of Serum or Plasma

159

2.13

3.89

3.9

2.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.84

3.88

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

180

2.06

3.86

1.6

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

2.47

3.84

1.9

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

4.00

3.81

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

8.83

3.78

2.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

2.69

3.76

1.2

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2.61

3.75

2.5

3.2

0.89

0.94

nmol/l

0.10

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.88

3.71

3.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

3.16

3.67

1.9

1.4

17532.57

155346.69

e6/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.55

3.62

1.9

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.79

3.61

3.5

4.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

151

2.10

3.57

1.3

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

7.85

3.56

1.3

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.85

3.54

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.85

3.54

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.85

3.54

1.4

1.6

—

(3024928) Oxygen saturation in Venous blood

112

2.28

3.52

24.6

5.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

182

1.97

3.40

1.6

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.05

3.38

1.7

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.05

3.38

1.7

3.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

183

1.96

3.35

1.6

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

2.45

3.33

1.4

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.40

3.32

5.9

2.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.96

3.31

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

109

2.25

3.29

1.1

0.27

7.21

u/ml

2.81

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.64

3.27

1.8

1.1

—

(1761868) Lipid panel - Serum or Plasma

257

2130

1.34

3.22

3.6

2.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

268

1.77

3.18

2.8

2.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

568

5317

1.48

3.10

4.8

3.9

1.55

1.29

mmol/l

9.01

529

4917

(3011397) Hemoglobin [Presence] in Urine by Test strip

163

1266

1.38

3.08

6.9

3.5

—

(3045424) Erythrocytes [Presence] in Urine

2.30

3.06

1.7

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

155

1.98

2.99

2.3

1.9

6.76

6.27

iu/l

0.07

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.06

2.98

3.2

4.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.67

2.98

1.2

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

266

1.74

2.97

15.7

6.2

25.60

24.89

mmol/l

1.06

259

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

123

916

1.42

2.97

4.0

2.8

3.37

1.01

e6/l

0.45

516

(3025018) Bordetella pertussis Ab [Titer] in Serum

3.28

2.94

1.2

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

665

0.58

2.94

5.9

4.4

31.51

32.35

0.22

455

(3009871) Measles virus Ab [Titer] in Serum

4.75

2.92

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

2.73

2.90

1.6

1.5

22.89

32.31

g/l

1.37

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

2.47

2.90

1.3

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.29

2.89

1.3

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

3.11

2.78

1.7

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.04

2.73

1.9

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

584

5528

1.47

2.69

5.4

4.4

4.67

4.75

mmol/l

1.15

548

5164

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

592

5622

1.49

2.64

5.8

4.9

2.64

2.82

mmol/l

4.80

554

5226

(1761482) Bacteria [#/volume] in Urine by Culture

141

1.95

2.64

7.1

4.1

—

(3008898) HLA-B27 [Presence]

231

1.73

2.58

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.63

2.58

1.0

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.04

2.57

1.8

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.04

2.57

1.8

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

4.04

2.57

25.8

14.8

—

(3036048) Francisella tularensis Ab [Titer] in Serum

7.19

2.55

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

2.14

2.51

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.84

2.47

1.8

2.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

2.49

2.46

3.4

2.4

0.32

1.80

g/24h

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

580

5502

1.43

2.44

5.3

4.3

1.52

1.50

mmol/l

0.44

545

5111

(4034850) Laboratory test

183

1.79

2.40

28.3

9.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

113

861

1.38

2.38

4.6

2.9

4.63

2.36

e6/l

1.02

466

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

6.29

2.37

1.4

1.0

—

(40768446) Kidney Pathology biopsy report

3.67

2.37

3.1

1.1

—

(3037121) Protein [Mass/volume] in Urine

184

1.78

2.36

6.1

4.2

1.03

0.31

g/l

0.75

(3024263) Appearance of Synovial fluid

3.24

2.31

2.1

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.24

2.31

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.24

2.31

1.1

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.24

2.31

1.1

1.3

—

(3045142) Bone marrow Pathology biopsy report

2.40

2.30

1.1

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.25

2.29

4.5

2.5

—

(3035285) Chloride [Moles/volume] in Venous blood

2.25

2.29

4.5

2.5

105.06

105.62

mmol/l

0.19

(3041354) Potassium [Moles/volume] in Venous blood

2.25

2.29

4.5

2.5

4.06

4.01

mmol/l

0.16

(21494890) Protein electrophoresis panel - 24 hour Urine

2.48

2.29

4.5

2.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

106

2.01

2.28

1.1

0.08

1.73

u/ml

—

(3028433) Virus identified in Specimen by Culture

3.51

2.27

1.0

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.51

2.27

1.8

1.2

9.66

8.51

ug/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

460

1.48

2.27

2.0

1.6

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

3.92

2.25

3.9

196.86

212.39

u/l

—

(3000492) Spirometry study

555

1.44

2.23

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.59

2.21

1.2

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.59

2.21

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

196

1.72

2.20

4.0

1.9

—

(3005570) Glucose [Moles/volume] in Urine

2.53

2.19

2.2

2.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

3.36

2.18

1.3

1.7

2.88

0.90

nmol/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.80

2.14

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.03

2.12

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.93

2.08

1.0

1.1

131.22

200.18

iu/ml

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

110

1.94

2.07

1.5

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.73

2.07

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.53

2.06

1.3

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.03

2.02

1.2

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.53

2.02

2.4

2.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

202

0.44

1.99

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

534

1.41

1.97

2.1

1.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

2.38

1.96

1.7

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.57

1.94

1.0

1.1

—

(3035880) pH of Pleural fluid

2.99

1.94

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.75

1.93

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.75

1.93

1.2

1.8

0.56

2.17

u/field

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

173

1.71

1.93

1.3

182.90

239.26

miu/ml

—

(3001019) Free T4 and TSH panel - Serum or Plasma

341

0.54

1.89

1.6

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.19

1.82

1.2

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.06

1.80

2.4

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.78

1.79

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.78

1.79

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

154

1278

1.27

1.77

5.3

4.8

10.56

2.45

ug/l

0.50

136

1150

(3002256) Pathology report gross observation

731

1.33

1.76

1.5

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.52

1.74

2.1

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.52

1.60

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.71

1.58

1.0

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.44

1.54

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

639

1.32

1.53

1.6

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.35

1.52

3.0

4.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

162

1.63

1.51

1.4

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

139

1.68

1.50

2.7

2.4

79.25

145.16

ug/min

0.51

(3045414) Leukocytes [Presence] in Urine

244

1.50

1.48

2.1

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.52

1.45

1.0

—

(40768795) Lymph node Pathology biopsy report

2.13

1.45

1.3

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

591

1.32

1.45

2.2

2.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.14

1.44

1.2

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

138

0.43

1.41

1.7

1.3

—

(3036180) Methadone [Presence] in Urine

2.62

1.37

1.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.96

1.36

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

1.77

1.36

3.9

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

184

1.54

1.34

4.0

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.79

1.28

1.0

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

211

1.49

1.27

1.6

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.41

1.24

1.3

—

(3045788) Cell count panel - Pleural fluid

2.24

1.24

1.6

1.2

—

(3023410) Appearance of Cerebral spinal fluid

1.89

1.18

1.7

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.89

1.18

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.02

1.17

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.98

1.11

1.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.98

1.11

1.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.20

1.08

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.67

1.07

1.1

1.0

—

13.41

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.94

1.06

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.94

1.06

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.94

1.06

1.0

1.2

—

(3011648) Oxygen content in Venous blood

1.97

1.04

8.7

7.1

12.27

10.94

—

(3004616) Nuclear Ab [Presence] in Serum

1.78

1.01

1.2

—

(3051651) Icteric interference index of Serum or Plasma

2.01

1.00

4.7

2.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

542

1.26

1.00

3.3

2.4

27.72

34.84

u/l

1.27

464

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

165

1.47

0.98

1.5

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.78

0.95

1.0

1.2

—

(3022621) pH of Urine by Test strip

349

1.31

0.93

6.5

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

101

0.49

0.90

1.4

1.6

—

(3003694) ABO and Rh group [Type] in Blood

173

1550

1.16

0.89

1.7

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

248

1.35

0.85

1.6

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1.79

0.84

2.0

1.2

401.38

2633.48

e6/l

—

(3014051) Protein [Presence] in Urine by Test strip

137

0.58

0.84

2.9

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

383

1.27

0.82

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

1.83

0.79

1.8

2.2

2.13

2.21

ug/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.77

0.0

1.4

—

(3049717) Cytology report of Urine Cyto stain

192

1.37

0.76

1.9

2.6

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

1.71

0.76

2.2

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.61

0.75

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.01

0.73

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.76

0.71

4.1

1.4

1.01

1.11

g/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

311

1.27

0.69

1.7

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1.60

0.68

1.0

1.1

0.06

0.07

u/ml

—

(3000330) Specific gravity of Urine by Test strip

268

1.28

0.66

6.9

3.3

—

(3047189) Immunofixation for 24 hour Urine

1.79

0.66

5.2

1.7

—

(3011288) Drugs identified in Urine by Screen method

137

1.40

0.65

5.4

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

146

1324

1.13

0.64

3.8

2.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.53

0.63

2.0

1.4

—

(40768806) Pleura Pathology biopsy report

1.64

0.62

1.6

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.64

0.62

1.1

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.67

0.61

14.4

6.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

220

0.72

0.60

1.4

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.57

0.59

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.52

0.58

1.1

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

149

1.35

0.58

1.4

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

658

1.16

0.54

18.2

6.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

751

0.87

0.50

3.5

3.0

1.05

0.79

ug/l

0.24

479

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

207

1.27

0.50

1.3

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

1.43

0.46

4.7

2.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.44

0.45

2.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.44

0.45

2.0

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.42

0.43

2.1

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.42

0.43

2.0

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.57

0.42

1.2

91.56

182.92

pmol/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.40

0.41

2.1

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.0

—

26.04

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

656

1.13

0.40

1.8

1.7

1.46

1.43

0.21

582

(3006462) Nitrate [Presence] in Urine

0.00

0.40

0.0

3.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.43

0.39

1.2

22.40

14.66

u/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

106

1.33

0.39

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

106

1.33

0.39

1.3

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.35

0.37

1.2

103.80

91.94

u/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

330

1.16

0.35

1.6

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

593

0.88

0.34

2.0

1.4

—

(3012441) Differential panel - Pleural fluid

1.37

0.34

1.7

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

158

1.21

0.28

4.1

1.4

—

(1002224) Polysomnography panel

261

1.16

0.28

1.1

—

(3044927) Protein electrophoresis panel - Urine

1.27

0.28

1.4

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.71

0.24

3.8

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.28

0.23

1.8

1.4

62.80

74.44

umol/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.0

—

(3033799) Differential panel - Peritoneal fluid

0.00

0.21

0.0

1.3

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.21

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.7

—

3.08

—

(3016879) Cocaine [Presence] in Urine

193

1.14

0.20

3.7

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.24

0.19

1.4

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

224

1.12

0.17

1.4

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

151

0.86

0.16

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

211

1.09

0.11

3.6

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

106

1030

1.03

0.10

1.7

1.4

—

(36660697) Celiac disease serology panel - Serum

469

1.05

0.08

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

107

1043

1.03

0.08

4.4

4.3

18.31

21.44

1.25

494

(3025130) Human papilloma virus identified in Specimen

1.07

0.07

1.1

1.7

—

(40768800) Prostate Pathology biopsy report

1.04

0.07

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.87

0.06

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

325

1.05

0.06

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

141

0.92

0.05

2.5

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

210

1.05

0.03

3.7

1.4

—

(3019225) pH of Specimen

512

0.97

0.03

6.7

4.0

—

(3028300) Cannabinoids [Presence] in Urine

211

1.04

0.03

3.7

1.4

—

(3027944) Amphetamines [Presence] in Urine

211

1.04

0.03

3.7

1.4

—

(40768793) Breast Pathology biopsy report

163

1.04

0.01

1.4

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

65.67

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

-0.00

0.0

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.5

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.1

—

(21494434) Karyotype in Bone marrow

1.02

-0.00

1.0

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

-0.00

0.0

4.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

2.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY and mortality.

Females

Parameter	HR [95% CI]	p-value
DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY	3.3 [2.56, 4.25]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.61

During the follow-up period (1.1.1998 — 31.12.2019), 228 out of 1280 females with DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY died.

Males

Parameter	HR [95% CI]	p-value
DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY	3.434 [2.34, 5.04]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 146 out of 676 males with DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY died.

Mortality risk

Mortality risk for people of age

years, who have DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY.

N-year risk	Females	Males
1	0.391%	0.637%
5	2.02%	4.028%
10	5.264%	9.927%
15	9.781%	17.921%
20	17.281%	28.456%

Relationships between endpoints

↥

Index endpoint: DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY – Drug-induced adrenocortical insufficiency

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced adrenocortical insufficiency

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints